PMID- 34466365 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210903 IS - 2364-3722 (Print) IS - 2196-9736 (Electronic) IS - 2196-9736 (Linking) VI - 9 IP - 9 DP - 2021 Sep TI - Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy. PG - E1397-E1403 LID - 10.1055/a-1499-6988 [doi] AB - Background and study aims Anticoagulation (AC) and antiplatelet (AP) therapy may increase the risk of gastrointestinal bleeding after double balloon enteroscopy (DBE); however, limited data are currently available regarding the incidence. The aim of this study was to assess the incidence and clinical characteristics of post-DBE bleeding in patients on AC and AP therapy. Patients and methods The medical records of patients who underwent DBE between 2009 and 2013 at Mayo Clinic, Florida, were retrospectively reviewed. Patients were divided into three groups: 1) continued AP therapy; 2) AC therapy; and 3) neither AP nor AC at the time of DBE. Follow-up data were collected at 60 days and 1 year. Results A total of 683 patients were identified; 43 on AC, 183 on AP and 457 not on AP or AC therapy. The most common indication for DBE was obscure gastrointestinal bleeding in the groups on and not on AP (85.3 % vs 70.9 %, P < 0.0001). There was no statistical difference in post-DBE bleeding rates in patients on AP vs not on AP at 60 days (11.5 % vs 7.5 %, P = 0.12) or 1 year (19.9 % vs 15.7 %, P = 0.23). Rates of bleeding in patients on AC were 11.6 % within 60 days and 22.5 % within 1 year. Multivariate analysis reflected American Society of Anesthesiologist > 3 and indication for DBE of GI bleeding were independent risk factors for post-DBE bleeding within 1 year. Conclusions Continued antiplatelet use at the time of DBE was not an independent risk factor for bleeding post-DBE at 60 days or 1 year of follow up. CI - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). FAU - Zaver, Himesh B AU - Zaver HB AD - Division of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States. FAU - Ghoz, Hassan AU - Ghoz H AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Stancampiano, Fernando AU - Stancampiano F AD - Division of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States. FAU - Alnahhal, Khaled I AU - Alnahhal KI AD - Division of Vascular Surgery, Mayo Clinic, Jacksonville, Florida, United States. FAU - Malviya, Balkishan AU - Malviya B AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Patel, Krupa AU - Patel K AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Rodriguez, Andrea C AU - Rodriguez AC AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Oberoi, Mansi AU - Oberoi M AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Koralewski, Andrea AU - Koralewski A AD - Division of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States. FAU - Crawford, Matthew J AU - Crawford MJ AD - Division of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States. FAU - Choudhry, Aruj AU - Choudhry A AD - Division of Gastroenterology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States. FAU - Mareth, Karl AU - Mareth K AD - Division of Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States. FAU - Werlang, Monia E AU - Werlang ME AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Kroner, Paul T AU - Kroner PT AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Simons-Linares, C Roberto AU - Simons-Linares CR AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Lukens, Frank AU - Lukens F AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Bartel, Michael J AU - Bartel MJ AD - Division of Gastroenterology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States. FAU - Stark, Mark AU - Stark M AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. FAU - Brahmbhatt, Bhaumik AU - Brahmbhatt B AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States. LA - eng PT - Journal Article DEP - 20210823 PL - Germany TA - Endosc Int Open JT - Endoscopy international open JID - 101639919 PMC - PMC8382496 COIS- Competing interests The authors declare that they have no conflict of interest. EDAT- 2021/09/02 06:00 MHDA- 2021/09/02 06:01 PMCR- 2021/08/01 CRDT- 2021/09/01 07:24 PHST- 2021/02/12 00:00 [received] PHST- 2021/04/25 00:00 [accepted] PHST- 2021/09/01 07:24 [entrez] PHST- 2021/09/02 06:00 [pubmed] PHST- 2021/09/02 06:01 [medline] PHST- 2021/08/01 00:00 [pmc-release] AID - 10.1055/a-1499-6988 [doi] PST - epublish SO - Endosc Int Open. 2021 Aug 23;9(9):E1397-E1403. doi: 10.1055/a-1499-6988. eCollection 2021 Sep.